Magic Doctor CEO Lady's Humble Husband (Fade Chen)
Chapter 718

Having a flash of inspiration, Norton returned to his kind expression. He wore a smile at the corner of his lips, seemingly in good spirits.

Loomis Chiang came to his senses and said immediately, "Mr. Norton, I'll arrange to meet Fade right away."

He paused for a moment, and went on, "However, the previous negotiations with Fade went pretty badly. If we look for him again, I'm afraid..."

Norton shook his head and interrupted, "I have an idea."

"Mr. Norton, what are you trying to..." Loomis was confused.

Norton smiled, 'TH visit Fade in person.

"In person?" Loomis was surprised, "Mr. Norton, you—"

Norton stood up and ordered, "Go fetch the car. We'll leave right away!"

After the meeting, Fade Chen bid goodbye to Daphne Tao and Mr. Tu. As soon as he returned to his office, his secretary came knocking on his door. "President Chen, you have a visitor."

"Who is it?" Fade asked.

The secretary replied, "It is Loomis Chiang from Maritime Ocean Pharma."

"Loomis, why is he here?" Fade frowned and wondered.

After all, their discussion had just ended.

The secretary added, "There is a foreigner who came with him. His name is Norton."

"A foreigner? Norton?" Fade pondered about it and still, he didn't know who this foreigner was. Although he was curious, he still waved his hand dismissively "I don't want to see them, tell them to leave." The secretary nodded and went to deliver the message.

However, before the secretary was able to reach them, she saw Loomis and Norton walking towards her.

"Sir, you can't..." The secretary was about to stop them.

Loomis shouted, "I want to see President Chen!" Then he reached out and pushed the secretary away.

When Fade saw this, he warned icily, "President Chiang, you're not at Maritime Ocean Pharma. Watch your actions."

As he spoke, Fade waved his arm and sent forth an invisible strength that pushed Loomis back.

Loomis stumbled and almost fell.

Loomis was furious. He glared at Fade, "Fade, how dare you?"

Fade sneered, "This is my office, you are trespassing on my property. This is the lightest punishment. Do you perhaps want to try a heavier punishment?" "You" Loomis was infuriated, he was close to blowing up.

Right at this moment, Norton appeared with a smile on his face, he spoke in Chinese and apologized to Fade, "President Chen, I'm sorry for our reckless behaviour." 'Now, Let me introduce myself. I'm Norton. I was wondering if you would have some time for a talk with us?" As he spoke, Norton passed a business card to the secretary. The secretary brought the business card to Fade. Fade glanced at the contents of the business card.

When Fade's gaze fell on the title of "Managing Director of Bald Eagle Pharma in the Asian region", his face lit up, and he looked at Norton.

Norton was smiling, wearing an expression full of confidence.

Fade remained silent for a moment. After a while, he said, "Cut to the chase, speak."

Hearing this, Loomis was boiling in rage, "Fade, what kind of attitude is this?"

"Do you know who Norton is? How can you be so rude?"

Fade said coldly, "I don't care if he is the Managing Director or the CEO. If you got nothing, then get out of here."

"You" Loomis pointed at Fade and was furious.

As for Norton, he remained smiling. He calmed Loomis and continued, "Since Mr. Chen said so, I'll say this outright."

"Bald Eagle Pharma wants to cooperate with you, Mr. Chen. It is about the Ephedra Syrup that you have recently developed. We would like to..."

Before he could finish, Fade frowned. He interrupted, "If this is about buying the patents for the Ephedra Syrup, there's no need to go on. I will not consent to it."

Norton smiled and said, "Mr. Chen, don't be in such a hurry to refuse. Why don't you listen to the contents of our offer?

"I won't agree to any of your offers." Fade waved his hand in rejection.

Seeing this, Loomis was raging once again. "Fade, are you aware of what you are doing? This is Mr. Norton we are talking about here, this might be your only chance to..."

Norton dismissed Loomis and went on, "I know that you are wise enough to understand the potential of the syrup. So I'll go straight to the point. Bald Eagle Pharma wants the patent of the Ephedra Syrup to..." "It's impo...?" Fade interrupted.

Before Fade Chen could finish his words, Norton persisted, "We're not going to buy the patent. Instead, we want to cooperate with you by profit distribution."

"Mr. Chen, if you agree, we shall pay you 100 million dollars. After that, you will also receive 5% from the net profits of the medicine sales."

Loomis was shocked when he heard Norton.

He was someone who worked in the pharmaceutical industry. Of course he knew how great Norton's offer was.

In the pharmaceutical industry, many laboratories and scientists would come up with various pharmaceutical formulations. However, due to a lack of resources for mass development, most of the formulations would end up being sold to major pharmaceutical companies.

There were usually two methods of selling the

formulation.

The first method was a one-off transaction. It would require the full payment and complete transfer of the patents. After that, the patent right of the drug would belong to the pharmaceutical company entirely, and have nothing more to do with the original developers of the medicine.

The other method was by profit distribution. The pharmaceutical company would first pay a sum of money to the developer. Next, the profit of the medicine sales would be distributed between the pharmaceutical company and the developer. In other words, the higher the sales, the higher the amount of money received by the developer.

There was no doubt that the second method was more promising. After all, every product sold would bring profit to the developer. The profit would be long-term and more rewarding compared to the one-off method.

Therefore, any developer who was confident about his own formulation would want to sell his patent by profit distribution. In doing so, they can get more profit.

Both developers and pharmaceutical companies were well aware of this concept.

Therefore, most of the pharmaceutical companies preferred to buy patents in a one-off transaction.

If the other party did not agree, they would rather not buy it, or invest their own manpower to develop a similar formulation.